Sweden · Delayed Price · Currency is SEK IRLAB Therapeutics AB Statistics
Total Valuation
STO:IRLAB.A has a market cap or net worth of SEK 262.33 million. The enterprise value is 252.31 million.
| Market Cap | 262.33M |
| Enterprise Value | 252.31M |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:IRLAB.A has 148.71 million shares outstanding. The number of shares has increased by 61.05% in one year.
| Current Share Class | 148.63M |
| Shares Outstanding | 148.71M |
| Shares Change (YoY) | +61.05% |
| Shares Change (QoQ) | +3.73% |
| Owned by Insiders (%) | 12.16% |
| Owned by Institutions (%) | 26.80% |
| Float | 119.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.31 |
| PB Ratio | 2.70 |
| P/TBV Ratio | 5.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.55 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.36 |
| Interest Coverage | -3.81 |
Financial Efficiency
Return on equity (ROE) is -155.06% and return on invested capital (ROIC) is -28.50%.
| Return on Equity (ROE) | -155.06% |
| Return on Assets (ROA) | -16.15% |
| Return on Invested Capital (ROIC) | -28.50% |
| Return on Capital Employed (ROCE) | -39.77% |
| Weighted Average Cost of Capital (WACC) | 9.52% |
| Revenue Per Employee | 2.56M |
| Profits Per Employee | -1.74M |
| Employee Count | 31 |
| Asset Turnover | 0.53 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.27% in the last 52 weeks. The beta is 0.56, so STO:IRLAB.A's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -42.27% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 63.98 |
| Average Volume (20 Days) | 1,917,908 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:IRLAB.A had revenue of SEK 79.33 million and -53.84 million in losses. Loss per share was -0.64.
| Revenue | 79.33M |
| Gross Profit | 787,000 |
| Operating Income | -38.63M |
| Pretax Income | -53.84M |
| Net Income | -53.84M |
| EBITDA | -37.95M |
| EBIT | -38.63M |
| Loss Per Share | -0.64 |
Balance Sheet
The company has 34.22 million in cash and 24.20 million in debt, with a net cash position of 10.02 million or 0.07 per share.
| Cash & Cash Equivalents | 34.22M |
| Total Debt | 24.20M |
| Net Cash | 10.02M |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 97.13M |
| Book Value Per Share | 0.65 |
| Working Capital | 46.86M |
Cash Flow
| Operating Cash Flow | -67.02M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 680,000 |
| Net Borrowing | -25.95M |
| Free Cash Flow | -67.02M |
| FCF Per Share | -0.45 |
Margins
Gross margin is 0.99%, with operating and profit margins of -48.69% and -67.87%.
| Gross Margin | 0.99% |
| Operating Margin | -48.69% |
| Pretax Margin | -67.87% |
| Profit Margin | -67.87% |
| EBITDA Margin | -47.83% |
| EBIT Margin | -48.69% |
| FCF Margin | n/a |
Dividends & Yields
STO:IRLAB.A does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -61.05% |
| Shareholder Yield | -61.05% |
| Earnings Yield | -20.52% |
| FCF Yield | -25.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 28, 2019. It was a forward split with a ratio of 5.
| Last Split Date | May 28, 2019 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
STO:IRLAB.A has an Altman Z-Score of -4.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.7 |
| Piotroski F-Score | 3 |